Search Results 281-290 of 16609 for mesenteric fat and ibd

1. Clinical trials - Gastroenterology and Hepatology

   Ulcerative Colitis (UC) is a chronic inflammatory disease affecting the mucosal lining of the colon and rectum and the incidence is increasing, ...

2. Publications - David W. Larson, M.D., M.B.A. - Mayo Clinic

   ... Ulcerative Colitis Undergoing Total Colectomy: A Retrospective Case-Control Study. Dis Colon Rectum. 2024 Nov 1; 67 (11):1443-1449 Epub 2024 Aug 01. View ...

3. Publications - Joel G. Fletcher, M.D. - Mayo Clinic

   International expert guidance for defining and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound: a consensus statement. Lancet ...

4. Fecal incontinence - Diagnosis and treatment - Mayo Clinic

   Common culprits include spicy foods, fatty and greasy foods, and dairy products. ... Have you ever been diagnosed with ulcerative colitis or Crohn's disease?

5. Nonpharmacological approaches to management of functional gastrointestinal disorders — Where are we now? - Mayo Clinic

   ... of dietary interventions and other nonpharmacological measures to manage irritable bowel syndrome and other functional gastrointestinal disorders (FGIDs).

6. Short bowel syndrome - Doctors and departments - Mayo Clinic

   This digestive condition happens when part of the small intestine is missing or damaged, either at birth or after surgery. The syndrome keeps you from ...

7. A Study to Evaluate the Effectiveness, Safety, and Tolerability of BOS-589 in the Treatment of Patients with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

   The purpose of this study is to evaluate abdominal pain response to BOS-589 in participants with diarrhea-predominant Irritable Bowel Syndrome (IBS-D) after 4 ...

8. VE202 in Patients With Mild-to-Moderate Ulcerative Colitis - Mayo Clinic

   The purpose of this study is to evaluate the safety, effectovemess, and microbiota changes of VE202 in patients with mild to moderate ulcerative colitis (UC).

9. A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome - Mayo Clinic

   A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome · Share · Facebook · Twitter.

10. Crohn's disease - Doctors and departments - Mayo Clinic

    Learn about symptoms and treatment for this debilitating, but treatable, digestive condition.